| Date |
Title |
|
|
December 1, 2021
|
Fulgent Genetics Confirms Ability to Detect Omicron Variant with RT-PCR Tests for COVID-19
|
|
|
November 9, 2021
|
Fulgent Genetics Reports Third Quarter Financial Results
|
|
|
November 9, 2021
|
Representatives of Fulgent Genetics to Participate in Upcoming Virtual Conferences
|
|
|
November 8, 2021
|
Helio Health and Fulgent Genetics Announce Late-Breaking Positive Performance Data of HelioLiver™ for Early Liver Cancer Detection
|
|
|
November 4, 2021
|
Fulgent Genetics Offers Multi-Omic Solutions to Pharma through Addition of Olink Proteomics Platform
|
|
|
November 1, 2021
|
Helio Health and Fulgent Genetics to Present New Data on HelioLiver in Late-Breaking Presentation at The Liver Meeting® 2021
|
|
|
October 27, 2021
|
Fulgent Genetics Launches At-Home Neutralizing Antibody Test for COVID-19
|
|
|
October 25, 2021
|
Fulgent Genetics to Announce Third Quarter 2021 Financial Results on Tuesday November 9, 2021
|
|
|
September 23, 2021
|
Fulgent Genetics to Partner with Houston Health Department and Houston-Area Public Schools on Back-to-School COVID-19 Testing Program
|
|
|
August 9, 2021
|
Fulgent Genetics Reports Second Quarter Financial Results
|
|
|
August 9, 2021
|
Fulgent Genetics Announces Acquisition of CSI Laboratories
|
|
|
August 9, 2021
|
Fulgent Genetics and Helio Health Announce Strategic Partnership to Commercialize Early Cancer Detection Tests
|
|
|
July 26, 2021
|
Fulgent Genetics to Announce Second Quarter 2021 Financial Results on Monday, August 9, 2021
|
|
|
May 10, 2021
|
Fulgent Genetics Announces Incremental Strategic Investment in Chinese Joint Venture, FF Gene Biotech
|
|
|
May 6, 2021
|
Fulgent Genetics Reports Record First Quarter Financial Results
|
|
|
May 6, 2021
|
Fulgent Genetics Welcomes Dr. Lawrence Weiss as Chief Medical Officer
|
|
|
April 16, 2021
|
Fulgent Genetics to Announce First Quarter 2021 Financial Results on Thursday May 6, 2021
|
|
|
March 15, 2021
|
Fulgent Genetics Awarded Contract from CDC to Study Variants of COVID-19 Virus
|
|
|
March 5, 2021
|
Fulgent Genetics to Participate in the Oppenheimer 31st Annual Healthcare Conference
|
|
|
March 4, 2021
|
Fulgent Genetics Reports Record Fourth Quarter and Full Year 2020 Financial Results
|
|
|
February 18, 2021
|
Fulgent Genetics to Announce Fourth Quarter and Full Year 2020 Financial Results on Thursday March 4, 2021
|
|
|
January 6, 2021
|
Fulgent Genetics to Participate in the H.C. Wainwright BIOCONNECT 2021 Conference
|
|
